Tarsus Pharmaceuticals (TARS) Prepaid Assets (2019 - 2026)

Tarsus Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $26.7 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 345.37% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $26.7 million (up 345.37% YoY), while the FY2025 annual figure was $13.5 million, down 8.03% from the prior year.
• Prepaid Assets for Q1 2026 stood at $26.7 million, up from $13.5 million in the prior quarter.
• The five-year high for Prepaid Assets was $29.2 million in Q2 2025, with the low at $3.1 million in Q1 2022.
• The 5-year median for Prepaid Assets is $6.0 million (2023), against an average of $10.0 million.
• Peak annual rise in Prepaid Assets reached 388.5% in 2025, while the deepest fall reached 11.82% in 2025.
• Tarsus Pharmaceuticals' Prepaid Assets stood at $4.8 million in 2022, then soared by 65.05% to $7.9 million in 2023, then jumped by 86.2% to $14.6 million in 2024, then retreated by 8.03% to $13.5 million in 2025, then jumped by 98.31% to $26.7 million in 2026.
• Business Quant data shows TARS's Prepaid Assets at $26.7 million in Q1 2026, $13.5 million in Q4 2025, and $21.7 million in Q3 2025.